corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 2185

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Glaxo Is Sued Over Antidepressant
The New York Times 2001 Aug 26
http://www.nytimes.com/2001/08/27/business/glaxo-is-sued-over-antidepressant.html?pagewanted=1


Full text:

A lawsuit accuses Glaxo SmithKline, the maker of the popular antidepressant Paxil, of concealing evidence that the drug can be addictive. The lawsuit was filed on Friday in Los Angeles Superior Court on behalf of 35 people nationwide who say they suffered symptoms ranging from electric-like shocks to suicidal thoughts after discontinuing use of the drug. The lawsuit, which seeks class-action status and unspecified damages, said that Glaxo concealed the possibility of physical and psychological withdrawal symptoms from the drug. It complains of fraud, deceit, negligence, liability and breach of warranty. There was no immediate comment from the company, based in Britain. Paxil was introduced in the United States in 1992 and is one of the nation’s largest-selling antidepressants.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








As an advertising man, I can assure you that advertising which does not work does not continue to run. If experience did not show beyond doubt that the great majority of doctors are splendidly responsive to current [prescription drug] advertising, new techniques would be devised in short order. And if, indeed, candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply.
- Pierre R. Garai (advertising executive) 1963